Transforming-growth-factor-b1	NN
(	(
TGFb1	NN
)	)
-	:
induced	VBN
CD44V6-NOX4	NN
signaling	NN
in	IN
pathogenesis	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
clinical	JJ
syndrome	NN
of	IN
fatal	JJ
outcome	NN
.	.

The	DT
lack	NN
of	IN
information	NN
about	IN
the	DT
signaling	NN
pathways	NNS
that	WDT
sustain	VBP
fibrosis	NN
and	CC
the	DT
myofibroblast	NN
phenotype	NN
has	VBZ
prevented	VBN
the	DT
development	NN
of	IN
targeted	VBN
therapies	NNS
for	IN
IPF	NN
.	.

Our	PRP$
previous	JJ
study	NN
showed	VBD
that	IN
isolated	VBN
fibrogenic	JJ
lung	NN
fibroblasts	NNS
have	VBP
high	JJ
endogenous	JJ
levels	NNS
of	IN
the	DT
hyaluronan	NN
receptor	NN
,	,
CD44V6	NN
(	(
CD44	NN
variant	NN
containing	VBG
exon	NN
6	CD
)	)
,	,
which	WDT
enhances	VBZ
the	DT
TGFb1	NN
autocrine	JJ
signaling	NN
and	CC
induces	VBZ
fibroblasts	NNS
to	TO
transdifferentiate	VB
into	IN
myofibroblasts	NNS
.	.

NADPH-oxidase-4	NN
(	(
NOX4	NN
)	)
enzyme	NN
,	,
which	WDT
catalyzes	VBZ
the	DT
reduction	NN
of	IN
O2	CD
to	TO
hydrogen	NN
peroxide	NN
(	(
H2O2	NN
)	)
,	,
has	VBZ
been	VBN
implicated	VBN
in	IN
the	DT
cardiac	JJ
and	CC
lung	NN
myofibroblast	NN
phenotype	NN
.	.

However	RB
,	,
whether	IN
CD44V6	NN
regulates	VBZ
NOX4	NN
to	TO
mediate	VB
tissue	NN
repair	NN
and	CC
fibrogenesis	NN
is	VBZ
not	RB
well-defined	JJ
.	.

The	DT
present	JJ
study	NN
assessed	VBD
the	DT
mechanism	NN
of	IN
how	WRB
TGF-b-1-induced	JJ
CD44V6	NN
regulates	VBZ
the	DT
NOX4/reactive	JJ
oxygen	NN
species	NNS
(	(
ROS	NN
)	)
signaling	NN
that	IN
mediates	VBZ
the	DT
myofibroblast	NN
differentiation	NN
.	.

Specifically	RB
,	,
we	PRP
found	VBD
that	IN
NOX4/ROS	NN
regulates	VBZ
hyaluronan	NN
synthesis	NN
and	CC
the	DT
transcription	NN
of	IN
CD44V6	NN
via	IN
an	DT
effect	NN
upon	IN
AP-1	NN
activity	NN
.	.

Further	RB
,	,
CD44V6	NN
is	VBZ
part	NN
of	IN
a	DT
positive-feedback	JJ
loop	NN
with	IN
TGFb1/TGFbRI	NN
signaling	NN
that	WDT
acts	VBZ
to	TO
increase	VB
NOX4/ROS	NN
production	NN
,	,
which	WDT
is	VBZ
required	VBN
for	IN
myofibroblast	NN
differentiation	NN
,	,
myofibroblast	NN
differentiation	NN
,	,
myofibroblast	NN
extracellular	JJ
matrix	NN
production	NN
,	,
myofibroblast	NN
invasion	NN
,	,
and	CC
myofibroblast	NN
contractility	NN
.	.

Both	DT
NOX4	NN
and	CC
CD44v6	NN
are	VBP
up-regulated	VBN
in	IN
the	DT
lungs	NNS
of	IN
mice	NNS
subjected	VBN
to	TO
experimental	JJ
lung	NN
injury	NN
and	CC
in	IN
cases	NNS
of	IN
human	JJ
IPF	NN
.	.

Genetic	JJ
(	(
CD44v6	JJ
shRNA	NN
)	)
or	CC
a	DT
small	JJ
molecule	NN
inhibitor	NN
(	(
CD44v6	NN
peptide	NN
)	)
targeting	NN
of	IN
CD44v6	NN
abrogates	VBZ
fibrogenesis	NN
in	IN
murine	JJ
models	NNS
of	IN
lung	NN
injury	NN
.	.

These	DT
studies	NNS
support	VBP
a	DT
function	NN
for	IN
CD44V6	NN
in	IN
lung	NN
fibrosis	NN
and	CC
offer	NN
proof	NN
of	IN
concept	NN
for	IN
therapeutic	JJ
targeting	NN
of	IN
CD44V6	NN
in	IN
lung	NN
fibrosis	NN
disorders	NNS
.	.

